Invention Grant
- Patent Title: Benzimidazole derivatives as bromodomain inhibitors
-
Application No.: US15239422Application Date: 2016-08-17
-
Publication No.: US10017501B2Publication Date: 2018-07-10
- Inventor: Evangelos Aktoudianakis , Gregory Chin , Britton Kenneth Corkey , Jinfa Du , Kristyna Elbel , Robert H. Jiang , Tetsuya Kobayashi , Rick Lee , Ruben Martinez , Samuel E. Metobo , Michael Mish , Manuel Munoz , Sophie Shevick , David Sperandio , Hai Yang , Jeff Zablocki
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D453/02 ; C07D417/04 ; C07D413/14 ; C07D471/04 ; C07D417/14

Abstract:
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, a bromodomain-containing protein, including bromodomain-containing protein 4 (BRD4), and to compositions and formulations containing such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I) wherein R1a, R1b, R2a, R2b, R3, R4a, R4b, and R5 are described herein.
Public/Granted literature
- US20160376261A1 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS Public/Granted day:2016-12-29
Information query